Nothing Special   »   [go: up one dir, main page]

BRET analysis reveals interaction between the lysophosphatidic acid receptor LPA2 and the lysophosphatidylinositol receptor GPR55 in live cells

FEBS Lett. 2021 Jul;595(13):1806-1818. doi: 10.1002/1873-3468.14102. Epub 2021 May 19.

Abstract

Lysophosphatidic acid (LPA) and lysophosphatidylinositol bind to the G protein-coupled receptors (GPCRs) LPA and GPR55, respectively. LPA2 , a type 2 LPA receptor, and GPR55 are highly expressed in colon cancer and involved in cancer progression. However, crosstalk between the two receptors and potential effects on cellular physiology are not fully understood. Here, using BRET analysis, we found that LPA2 and GPR55 interact in live cells. In the presence of both receptors, LPA2 and/or GPR55 activation facilitated co-internalization, and activation of GPR55, uncoupled with Gαi , induced reduction of intracellular cAMP. Notably, co-activation of receptors synergistically triggered further decline in the cAMP level, promoted cell proliferation, and increased the expression of cancer progression-related genes, suggesting that physical and functional crosstalk between LPA2 and GRR55 is involved in cancer progression.

Keywords: bioluminescence resonance energy transfer technique; cAMP; crosstalk; hypoxia-inducible factor 1α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bioluminescence Resonance Energy Transfer Techniques
  • Cell Proliferation
  • Colonic Neoplasms / metabolism*
  • Cyclic AMP / metabolism
  • Disease Progression
  • Gene Expression Regulation, Neoplastic
  • HCT116 Cells
  • HEK293 Cells
  • Humans
  • Protein Binding
  • Receptors, Cannabinoid / metabolism*
  • Receptors, Lysophosphatidic Acid / metabolism*
  • Signal Transduction
  • Up-Regulation*

Substances

  • GPR55 protein, human
  • LPAR2 protein, human
  • Receptors, Cannabinoid
  • Receptors, Lysophosphatidic Acid
  • Cyclic AMP